INS and Hyperglycemia: The increased presence of ROS in overweight and obese individuals may affect the apoptosis of Langerhans cells in the pancreas, disrupting the glucose-insulin balance and leading to hyperglycemia, further increasing OS levels (Robertson and Harmon, 2006).